How I diagnose myeloid neoplasms with germline predisposition.
Nisha PatelKatherine R CalvoPublished in: American journal of clinical pathology (2023)
Recognizing germline predisposition to myeloid neoplasia is critical for proper disease management. This recognition is particularly important for patients who will undergo hematopoietic stem cell transplantation to screen potential related donors. Integration of the clinical history, bone marrow findings, cytogenetic studies, and specialized laboratory and molecular genetic testing is often essential for accurate diagnosis and subsequent disease monitoring.